Correspondence 0001493152-23-039665 from Tharimmune, Inc. (THAR) (CIK 0001861657) (THAR)
Tharimmune, Inc. (THAR) (CIK 0001861657)
Date: Nov. 7, 2023 · CIK: 0001861657 · Accession: 0001493152-23-039665
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275350
Letter
THARIMMUNE, INC.
Route 22 East, Suite 2000
Bridgewater, NJ 08807
November 7, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, DC 20549
Re: Delaying Amendment for Tharimmune, Inc.
Registration Statement on Form S-1 (File No. 333-275350)
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-1(File No. 333-275350) filed with the Securities and Exchange Commission (the “Commission”) by Tharimmune, Inc. on November 6, 2023 (the “Registration Statement”). Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated into the facing page of the Registration Statement:
“The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.”
No fees are required in connection with this filing. If you have any questions or comments in connection with this delaying amendment, please contact our legal counsel Jeffrey Fessler at (212) 634-3067.
Sincerely,
Tharimmune,
Inc.
Show Raw Text
CORRESP
1
filename1.htm
THARIMMUNE,
INC.
1200
Route 22 East, Suite 2000
Bridgewater,
NJ 08807
November
7, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Re:
Delaying
Amendment for Tharimmune, Inc.
Registration
Statement on Form S-1 (File No. 333-275350)
Ladies
and Gentlemen:
Reference
is made to the Registration Statement on Form S-1(File No. 333-275350) filed with the Securities and Exchange Commission (the “Commission”)
by Tharimmune, Inc. on November 6, 2023 (the “Registration Statement”). Pursuant to Rule 473(c) of the Securities Act of
1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated
into the facing page of the Registration Statement:
“The
registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective
on such date as the Commission, acting pursuant to said Section 8(a), may determine.”
No
fees are required in connection with this filing. If you have any questions or comments in connection with this delaying amendment, please
contact our legal counsel Jeffrey Fessler at (212) 634-3067.
Sincerely,
Tharimmune,
Inc.
/s/
Randy Milby
By:
Randy
Milby
Title:
Chief
Executive Officer